Table 3.
Number (percentage) of patients in groups differing in the location of a primary site and a 12-month survival or 24-month survival, the result of the test of independence and odds ratio (95% confidence interval)
| Primary site of cancer | 12-month survival | P-value | OR (95% CI) | |
|---|---|---|---|---|
| Yes N=65 |
No N=31 |
|||
| Oropharynx, nasopharynx or larynx | 57 (87.7%) | 14 (45.2%) | <0.001 | 8.65 (3.11– 24.1) |
| Laryngophanyx, lung or salivary gland | 8 (12.3%) | 17 (54.8%) | 1.00 (ref.) | |
| Primary site of cancer | 24-month survival | P-value | OR (95% CI) | |
| Yes N=44 |
No N=52 |
|||
| Oropharynx, nasopharynx or larynx | 40 (90.9%) | 31 (59.6%) | <0.001 | 6.77 (2.11– 21.8) |
| Laryngophanyx, lung or salivary gland | 4 (9.1%) | 21 (40.4%) | 1.00 (ref.) | |